Interpret 18-Oxocortisol Levels for PA Subtyping
STEP 1 — Gather Information
Collect peripheral plasma 18-oxocortisol concentration (ng/dL) in a patient with confirmed primary aldosteronism (positive ARR) and note clinical context (e.g., hypertension, hypokalemia). Also record whether the sample is peripheral or from adrenal venous sampling if available.
STEP 2 — Rule In / Rule Out
If 18-oxocortisol >100 ng/dL (or above the laboratory's upper reference limit for idiopathic hyperplasia), rule in unilateral aldosterone-producing adenoma; otherwise, rule out unilateral source (suggest bilateral idiopathic hyperplasia).
STEP 3 — Classify or Stratify
Stratify as high (>100 ng/dL) favoring unilateral APA, low (≤100 ng/dL) favoring bilateral IHA, noting that up to 40% of patients may have indeterminate levels requiring further testing.
STEP 4 — Decide
For high 18-oxocortisol suggesting unilateral disease, proceed to laparoscopic adrenalectomy if surgical candidate; for low levels suggesting bilateral disease, initiate medical treatment with a mineralocorticoid receptor antagonist (e.g., spironolactone).
Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on 18-oxocortisol for surgical decisions; confirm unilateral disease with adrenal venous sampling. Avoid using 18-oxocortisol in patients with renal insufficiency, as metabolite excretion may be unreliable. Recognize that assay standardization varies and results may not be available in all labs.
Concrete Clinical Example
A 52-year-old man with resistant hypertension and spontaneous hypokalemia has an ARR of 60. Peripheral plasma 18-oxocortisol returns at 135 ng/dL. This elevated level supports a unilateral source, and subsequent AVS confirms left-sided aldosterone excess, leading to laparoscopic left adrenalectomy.
Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-4061